Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Houston Thompson

Showing results (121-130 of 374) with videos related to

Pageof 38
Sort By:
The Journal of Urology|March 17, 2009
Tumor size is associated with malignant potential in renal cell carcinoma casesR Houston Thompson, Jordan M Kurta, Matthew Kaag, et al.
European Urology Open Science|February 16, 2023
Bladder Recurrence Following Upper Tract Surgery for Urothelial Carcinoma: A Contemporary Review of Risk Factors and Management StrategiesLaura S Mertens, Vidit Sharma, Surena F Matin, et al.
Journal of Clinical Medicine|January 23, 2024
Navigating Now and Next: Recent Advances and Future Horizons in Robotic Radical ProstatectomyAbrar H Mian, Matthew K Tollefson, Paras Shah, et al.
The Journal of Urology|February 16, 2005
Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a?R Houston Thompson, Bradley C Leibovich, John C Cheville, et al.
European Urology|January 22, 2013
The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomyBrian J Linder, Igor Frank, John C Cheville, et al.
European Urology|March 18, 2014
Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomyBoyd R Viers, Stephen A Boorjian, Igor Frank, et al.
Urology|June 21, 2020
Treatment Outcomes in Patients With Symptomatic Lymphoceles Following Radical Prostatectomy Depend Upon Size and Presence of InfectionJack R Andrews, Ilya Sobol, Igor Frank, et al.
The Journal of Urology|February 16, 2005
Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved?Bradley C Leibovich, John C Cheville, Christine M Lohse, et al.
BJU International|September 7, 2013
Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patientsR Houston Thompson, Stephen A Boorjian, Simon P Kim, et al.
European Urology Oncology|June 4, 2019
The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal MassesMaciej Salagierski, Adrianna Wojciechowska, Kinga Zając, et al.
Pageof 38

Showing results (121-130 of 374) with videos related to

Sort By:
Pageof 38
The Journal of Urology|March 17, 2009
Tumor size is associated with malignant potential in renal cell carcinoma casesR Houston Thompson, Jordan M Kurta, Matthew Kaag, et al.
European Urology Open Science|February 16, 2023
Bladder Recurrence Following Upper Tract Surgery for Urothelial Carcinoma: A Contemporary Review of Risk Factors and Management StrategiesLaura S Mertens, Vidit Sharma, Surena F Matin, et al.
Journal of Clinical Medicine|January 23, 2024
Navigating Now and Next: Recent Advances and Future Horizons in Robotic Radical ProstatectomyAbrar H Mian, Matthew K Tollefson, Paras Shah, et al.
The Journal of Urology|February 16, 2005
Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a?R Houston Thompson, Bradley C Leibovich, John C Cheville, et al.
European Urology|January 22, 2013
The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomyBrian J Linder, Igor Frank, John C Cheville, et al.
European Urology|March 18, 2014
Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomyBoyd R Viers, Stephen A Boorjian, Igor Frank, et al.
Urology|June 21, 2020
Treatment Outcomes in Patients With Symptomatic Lymphoceles Following Radical Prostatectomy Depend Upon Size and Presence of InfectionJack R Andrews, Ilya Sobol, Igor Frank, et al.
The Journal of Urology|February 16, 2005
Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved?Bradley C Leibovich, John C Cheville, Christine M Lohse, et al.
BJU International|September 7, 2013
Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patientsR Houston Thompson, Stephen A Boorjian, Simon P Kim, et al.
European Urology Oncology|June 4, 2019
The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal MassesMaciej Salagierski, Adrianna Wojciechowska, Kinga Zając, et al.
Pageof 38